Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Mallinckrodt
AstraZeneca
McKinsey
Harvard Business School
Fish and Richardson
Boehringer Ingelheim
McKesson
Deloitte
Julphar

Generated: August 17, 2017

DrugPatentWatch Database Preview

Ceftazidime - Generic Drug Details

« Back to Dashboard

What are the generic sources for ceftazidime and what is the scope of ceftazidime patent protection?

Ceftazidime
is the generic ingredient in ten branded drugs marketed by Glaxosmithkline, B Braun, Hospira, Lilly, Acs Dobfar, Teligent, Aurobindo Pharma Ltd, Wockhardt, and Baxter Hlthcare, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for ceftazidime. Seven suppliers are listed for this compound.

Summary for Generic Name: ceftazidime

Tradenames:10
Patents:0
Applicants:9
NDAs:16
Drug Master File Entries: see list17
Suppliers / Packagers: see list7
Bulk Api Vendors: see list50
Clinical Trials: see list44
Patent Applications: see list7,577
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ceftazidime at DailyMed

Pharmacology for Ingredient: ceftazidime

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
TAZICEF
ceftazidime
INJECTABLE;INJECTION064032-001Oct 31, 1993APRXNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
CEPTAZ
ceftazidime
INJECTABLE;INJECTION050646-004Sep 27, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
PENTACEF
ceftazidime
INJECTABLE;INJECTION063322-002Nov 7, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
TAZIDIME
ceftazidime
INJECTABLE;INJECTION062655-002Nov 20, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Teligent
FORTAZ
ceftazidime
INJECTABLE;INJECTION050578-004Jul 19, 1985APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
McKesson
Moodys
Cipla
US Department of Justice
Fuji
Queensland Health
Colorcon
Julphar
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot